Petros Pharmaceuticals is focused on innovating within the self-care market, particularly by transforming prescription medications into Over-the-Counter (OTC) treatment options. The company aims to enhance access to essential pharmaceuticals, specifically targeting erectile dysfunction (ED) therapies. Their flagship product is a prescription-grade therapeutic for ED, which they are working to potentially designate as an OTC option. If approved by the FDA, this would mark a significant milestone as it could be the first of its kind to achieve such status, thereby establishing a platform for the development of additional prescription therapeutics.

In addition to their OTC initiatives, Petros Pharmaceuticals also emphasizes the use of vacuum therapy systems, which have been effective in helping many men manage erectile dysfunction. This technology represents a non-invasive treatment option that complements their pharmaceutical offerings. By leveraging these technologies, Petros Pharmaceuticals is committed to addressing unmet healthcare needs and driving health equity, ultimately striving to make vital medications more accessible to consumers without the necessity of a physician's prescription.

United States

At Petros, we are bringing new approaches to the most challenging conditions in men's health. We seek to understand the various health phases throughout a man’s journey. We collaborate with researchers, scientists, medical thought leaders and payers to ensure our therapies aid in restoring men’s body function to vitality.

Please see the full Prescribing Information and Patient Information: 
https://stendra.com/wp-content/uploads/2022/04/stendra-prescribing-information.pdf 
https://stendra.com/wp-content/uploads/2022/04/stendra-patient-information.pdf 

Petros Pharmaceuticals

Company Details